These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 1486065

  • 1. Iron(III) chelating resins II. 3-Hydroxy-4(1H)-pyridinones-sepharose gels.
    Feng M, van der Does L, Bantjes A.
    J Biomater Sci Polym Ed; 1992; 4(2):145-54. PubMed ID: 1486065
    [Abstract] [Full Text] [Related]

  • 2. Iron(III) chelating resins--I. Preparation and properties of Sepharose-desferrioxamine gels.
    Feng M, van der Does L, Bantjes A.
    J Biomater Sci Polym Ed; 1992; 4(2):99-105. PubMed ID: 1486067
    [Abstract] [Full Text] [Related]

  • 3. Preparation of apolactoferrin with a very low iron saturation.
    Feng M, van der Does L, Bantjes A.
    J Dairy Sci; 1995 Nov; 78(11):2352-7. PubMed ID: 8747325
    [Abstract] [Full Text] [Related]

  • 4. Iron removal from milk and other nutrient media with a chelating resin.
    Feng M, van der Does L, Bantjes A, de Groote JM.
    J Dairy Sci; 1995 Jan; 78(1):55-61. PubMed ID: 7738259
    [Abstract] [Full Text] [Related]

  • 5. New hydroxypyridinone-functionalized sepharoses as sorbing agents for hard metal ions.
    Grazina R, Santos MA.
    J Hazard Mater; 2011 Feb 28; 186(2-3):1902-8. PubMed ID: 21239106
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, physicochemical properties, and evaluation of N-substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones.
    Rai BL, Dekhordi LS, Khodr H, Jin Y, Liu Z, Hider RC.
    J Med Chem; 1998 Aug 27; 41(18):3347-59. PubMed ID: 9719587
    [Abstract] [Full Text] [Related]

  • 7. Iron (III)-chelating resins. 3. Synthesis, iron (III)-chelating properties, and in vitro antibacterial activity of compounds containing 3-hydroxy-2-methyl-4(1H)-pyridinone ligands.
    Feng MH, van der Does L, Bantjes A.
    J Med Chem; 1993 Sep 17; 36(19):2822-7. PubMed ID: 8410996
    [Abstract] [Full Text] [Related]

  • 8. Acyclonucleoside iron chelators of 1-(2-hydroxyethoxy)methyl-2-alkyl-3-hydroxy-4-pyridinones: potential oral iron chelation therapeutics.
    Liu G, Men P, Kenner GH, Miller SC, Bruenger FW.
    Nucleosides Nucleotides Nucleic Acids; 2004 Sep 17; 23(3):599-611. PubMed ID: 15113026
    [Abstract] [Full Text] [Related]

  • 9. Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential.
    Dobbin PS, Hider RC, Hall AD, Taylor PD, Sarpong P, Porter JB, Xiao G, van der Helm D.
    J Med Chem; 1993 Aug 20; 36(17):2448-58. PubMed ID: 8355246
    [Abstract] [Full Text] [Related]

  • 10. Spectroscopic and potentiometric characterization of oxovanadium(IV) complexes formed by 3-hydroxy-4-pyridinones. Rationalization of the influence of basicity and electronic structure of the ligand on the properties of V(IV)O species in aqueous solution.
    Rangel M, Leite A, João Amorim M, Garribba E, Micera G, Lodyga-Chruscinska E.
    Inorg Chem; 2006 Oct 02; 45(20):8086-97. PubMed ID: 16999406
    [Abstract] [Full Text] [Related]

  • 11. Combined chelation of bi-functional bis-hydroxypiridinone and mono-hydroxypiridinone: synthesis, solution and in vivo evaluation.
    Gama S, Gil M, Gano L, Farkas E, Amélia Santos M.
    J Inorg Biochem; 2009 Feb 02; 103(2):288-98. PubMed ID: 19091421
    [Abstract] [Full Text] [Related]

  • 12. Structures of 3-hydroxy-1-(2-methoxyethyl)-2-methyl-4-pyridinone, its hydrochloride and 1-ethyl-3-hydroxy-2-methyl-4-pyridinone hydrochloride hydrate.
    Xiao G, van der Helm D, Goerlitz FH, Hider RC, Dobbin PS.
    Acta Crystallogr C; 1993 Sep 15; 49 ( Pt 9)():1646-9. PubMed ID: 8217022
    [Abstract] [Full Text] [Related]

  • 13. Carbohydrate-appended 3-hydroxy-4-pyridinone complexes of the [M(CO)3]+ core (M = Re, 99mTc, 186Re).
    Ferreira CL, Bayly SR, Green DE, Storr T, Barta CA, Steele J, Adam MJ, Orvig C.
    Bioconjug Chem; 2006 Sep 15; 17(5):1321-9. PubMed ID: 16984143
    [Abstract] [Full Text] [Related]

  • 14. New tripodal hydroxypyridinone based chelating agents for Fe(III), Al(III) and Ga(III): Synthesis, physico-chemical properties and bioevaluation.
    Grazina R, Gano L, Sebestík J, Amelia Santos M.
    J Inorg Biochem; 2009 Feb 15; 103(2):262-73. PubMed ID: 19062099
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and iron(III)-chelating properties of novel 3-hydroxypyridin-4-one hexadentate ligand-containing copolymers.
    Zhou T, Kong XL, Liu ZD, Liu DY, Hider RC.
    Biomacromolecules; 2008 May 15; 9(5):1372-80. PubMed ID: 18373358
    [Abstract] [Full Text] [Related]

  • 16. Novel 3-hydroxy-2(1H)-pyridinones. Synthesis, iron(III)-chelating properties, and biological activity.
    Streater M, Taylor PD, Hider RC, Porter J.
    J Med Chem; 1990 Jun 15; 33(6):1749-55. PubMed ID: 2342069
    [Abstract] [Full Text] [Related]

  • 17. A new approach for potential combined chelation therapy using mono- and bis-hydroxypyridinones.
    Santos MA, Gama S, Gil M, Gano L.
    Hemoglobin; 2008 Jun 15; 32(1-2):147-56. PubMed ID: 18274992
    [Abstract] [Full Text] [Related]

  • 18. Iron(III)-chelating resins. IX. Antibacterial activity of a water-insoluble iron(III)-chelating resin.
    Feng M, van der Does L, Bantjes A.
    J Med Chem; 1994 Apr 01; 37(7):924-7. PubMed ID: 8151619
    [Abstract] [Full Text] [Related]

  • 19. Molecular structure and biological and pharmacological properties of 3-hydroxy-2-methyl-1-(beta-D-ribofuranosyl or pyranosyl)-4-pyridinone: potential iron overload drugs for oral administration.
    Liu G, Bruenger FW, Miller SC, Arif AM.
    Bioorg Med Chem Lett; 1998 Nov 03; 8(21):3077-80. PubMed ID: 9873679
    [Abstract] [Full Text] [Related]

  • 20. The influence of linkages between 1-hydroxy-2(1H)-pyridinone coordinating groups and a tris(2-aminoethyl)amine core in a novel series of synthetic hexadentate iron(III) chelators on antimicrobial activity.
    Workman DG, Hunter M, Wang S, Brandel J, Hubscher V, Dover LG, Tétard D.
    Bioorg Chem; 2020 Jan 03; 95():103465. PubMed ID: 31855824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.